Sir, males and 5 females, age range 19-56 years) and in 9 healthy controls cross-matched for sex and age. After Since Gill et al. 's [1] original description of increased urine extraction with organic solvents and silica gel col-urinary excretion of prostaglandin E2 (PGE2) in Bartter's umn chromatography [3] , PGE2 and PGF2α were assayedsyndrome, many controversies have arisen about the role as previously described [4] , and 6-keto-PGF,α and TxB2played by prostaglandins in this disease, and it is still by the use of commercially available kits (Amersham, debated whether prostaglandin overproduction is a conAmersham, UK). stant feature and which prostanoid is more frequently As far as the mean urinary excretion is concerned, in involved.
Bartter's syndrome we found a significant increase in Different prostanoids, in fact, sometimes exert oppo-PGE2 (627.5 ± 275.6 vs. 359.6 ± 126.6 ng/day; t = 2.62, site effects on renal handling of electrolytes, regulation of p < 0.02) and .3renin release and renal action of antidiuretic hormone, ng/day; t = 3.09, p < O.Ol), a significant decrease in TxB2and can counteract the intrarenal action of angiotensin II (123.2 ± 57.3 vs. 184.1 ± 43.9 ng/day; t = 2.47, p < 0.05)in diffferent ways [2] . Therefore, it should be important to and no difference in PGF2α (1,588.6 ± 588.1 vs.know the full urinary pattern of the main arachidonic 1,500.4 ± 488.8 ng/day; t = 0.33, p = n.s.). However, con-acid metabolites in patients affected by Bartter's synsidering the cutoff values corresponding to eitherdrome to clarify the role played by prostanoids in this mean + 1.64 SD or mean -1.64 SD (i.e. the one-sided 95thsyndrome, but it has never been done. or 5th percentile, respectively), the picture becomes more We have addressed this issue trying to answer two complicated. In fact, PGE2 values were above the upper main questions: which prostaglandin of the cyclooxygelimit in 4 patients, no PGF2α values were above the nornase pathway is more frequently involved in Bartter's mal range, 6-keto-PGFια values were above the upper syndrome and whether a derangement in prostaglandin limit in 6 patients, and TxB2 values were above the upper synthesis is in a hallmark of the disease. limit in 4 patients ( fig. 1 ). To this end we have evaluated the urinary excretion of According to these data, we conclude that it is impos-PGE2, PGF2α, 6-keto-PGFlα, the main metabolite of sible to distinguish between healthy controls and patients PGI2, and thromboxane B2 (TxB2), the main metabolite of affected by Bartter's syndrome in terms of a single prostaTxA2, in 8 patients affected by Bartter's syndrome (3 glandin excretion. However, since the trend of the mean * B C Fig. 1 . Distribution of the 4 prostanoids PGE2 (a), PGF2α (b), 6-keto-PGFlα (c) and TxB2 (d), and PGE2 × 6-keto-PGF,α/TxB2 ratio (e) in 9 healthy controls (C) and in 8 patients affected by Bartter's syndrome (B) . Cutoff values, corresponding either to the 95th or 5th percentile of the controls, are represented by dashed lines. a 1,000 -‚ 500-: ⅜ b ⅞OOO 1,500 -¾ > 1000 CO J cn C, 500 250 -t-< ¿ 0 200 « ιoo-A • t t ** 452 Calò/Cantaro/Piccoli/Favaro/Bonfante/Borsatti values pointed toward an increased production of vaso-dilatory prostaglandins together with a reduction of TxB2, we have also considered the ratio PGE2 × 6-keto-PGFlα/TxB2. This approach seems to improve the discrimination between patients and controls since the ratio fell above the upper limit (95%) of the controls in 7 patients, but it was still in the normal range in 1 ( fig. 1) . However, by the use of multivariate discriminant analysis [5] , taking into account all 4 prostanoids it was possible to fully discriminate between patients and controls. Moreover, the symmetry of both the weight and sign of the standardized coefficients of the discriminant
